PrEP vs. PEP for HIV Prevention

Episode 8

PrEP vs. PEP for HIV Prevention

In Episode 8, Erin Everett, NP-C, AAHIVS, discusses PrEP vs. PEP for HIV Prevention. A certified HIV Specialist, Erin provides an overview of the differences between Pre-Exposure and Post-Exposure Prophylaxis drugs Truvada and Descovy, and explains administration, side effects, efficacy rates, and risk factors to determine who should be using these HIV Prevention drugs.

About This Episode

In episode eight of Exclusively Inclusive with Erin Everett, NP-C, your host provides an in-depth overview of PrEP vs. PEP for HIV prevention.

During the episode, Erin, who is an HIV Specialist certified by the American Academy of HIV Medicine, discusses the primary differences between Pre-Exposure and Post-Exposure Prophylaxis drugs Truvada and Descovy.  Erin discusses when these two drugs, both manufactured by Gilead, should be taken to prevent the transmission of HIV.

The overview of the two PrEP vs. PEP drugs for HIV includes how each drug should be administered, what the potential side effects are, and what the efficacy rates are for each when taken as directed by your medical provider. Erin highlights certain risk factors for needing to be on PrEP, including anal and vaginal sex with an HIV positive partner, and intravenous drug usage.

Episode Links:

PrEP vs. PEP for HIV Prevention